These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 25343663)
1. "Do you think you have mental health problems?": advantages and disadvantages of a single screening question for mental disorder in substance use disorder treatment. Veldhuizen S; Rush B; Urbanoski K J Stud Alcohol Drugs; 2014 Nov; 75(6):1039-46. PubMed ID: 25343663 [TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of diagnostic accuracy of four screening tools for mental disorders in people seeking treatment for substance use disorders. Rush B; Castel S; Brands B; Toneatto T; Veldhuizen S J Subst Abuse Treat; 2013 Apr; 44(4):375-83. PubMed ID: 23098381 [TBL] [Abstract][Full Text] [Related]
3. Global Appraisal of Individual Needs Short Screener (GSS): psychometric properties and performance as a screening measure in adolescents. McDonell MG; Comtois KA; Voss WD; Morgan AH; Ries RK Am J Drug Alcohol Abuse; 2009; 35(3):157-60. PubMed ID: 19462299 [TBL] [Abstract][Full Text] [Related]
4. Screening for serious mental illness in the general population. Kessler RC; Barker PR; Colpe LJ; Epstein JF; Gfroerer JC; Hiripi E; Howes MJ; Normand SL; Manderscheid RW; Walters EE; Zaslavsky AM Arch Gen Psychiatry; 2003 Feb; 60(2):184-9. PubMed ID: 12578436 [TBL] [Abstract][Full Text] [Related]
5. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203 [TBL] [Abstract][Full Text] [Related]
6. Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization. Prochaska JJ; Sung HY; Max W; Shi Y; Ong M Int J Methods Psychiatr Res; 2012 Jun; 21(2):88-97. PubMed ID: 22351472 [TBL] [Abstract][Full Text] [Related]
7. Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6 scale. Swartz JA; Lurigio AJ J Subst Abuse Treat; 2006 Oct; 31(3):287-96. PubMed ID: 16996391 [TBL] [Abstract][Full Text] [Related]
8. Do they actually work across borders? Evaluation of two measures of psychological distress as screening instruments in a non Anglo-Saxon country. Carrà G; Sciarini P; Segagni-Lusignani G; Clerici M; Montomoli C; Kessler RC Eur Psychiatry; 2011 Mar; 26(2):122-7. PubMed ID: 20620023 [TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Kessler psychological scales in a Swiss young-adult community sample indicate poor suitability for community screening for mental disorders. Osman N; Chow WS; Michel C; Meisenzahl E; Schimmelmann BG; Schultze-Lutter F Early Interv Psychiatry; 2023 Jan; 17(1):85-95. PubMed ID: 35352501 [TBL] [Abstract][Full Text] [Related]
10. The performance of the K10, K6 and GHQ-12 to screen for present state DSM-IV disorders among disability claimants. Cornelius BL; Groothoff JW; van der Klink JJ; Brouwer S BMC Public Health; 2013 Feb; 13():128. PubMed ID: 23402478 [TBL] [Abstract][Full Text] [Related]
11. Performance of the 6-item Kessler scale for measuring serious mental illness in Hong Kong. Lee S; Tsang A; Ng KL; Ma YL; Guo W; Mak A; Kwok K Compr Psychiatry; 2012 Jul; 53(5):584-92. PubMed ID: 22104556 [TBL] [Abstract][Full Text] [Related]
12. Validation of Six Short and Ultra-short Screening Instruments for Depression for People Living with HIV in Ontario: Results from the Ontario HIV Treatment Network Cohort Study. Choi SK; Boyle E; Burchell AN; Gardner S; Collins E; Grootendorst P; Rourke SB; PLoS One; 2015; 10(11):e0142706. PubMed ID: 26566285 [TBL] [Abstract][Full Text] [Related]
13. The ability of single screening questions for unhealthy alcohol and other drug use to identify substance dependence in primary care. Saitz R; Cheng DM; Allensworth-Davies D; Winter MR; Smith PC J Stud Alcohol Drugs; 2014 Jan; 75(1):153-7. PubMed ID: 24411807 [TBL] [Abstract][Full Text] [Related]
14. Validation of Addiction Severity Index (ASI) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials. Susukida R; Mojtabai R; Amin-Esmaeili M J Dual Diagn; 2020; 16(3):312-321. PubMed ID: 32254003 [No Abstract] [Full Text] [Related]
15. The Psychometric Properties of the Kessler Psychological Distress Scale (K6) in an Epidemiological Sample of Canadian Youth. Ferro MA Can J Psychiatry; 2019 Sep; 64(9):647-657. PubMed ID: 30602296 [TBL] [Abstract][Full Text] [Related]
16. Validity and reliability of the COJAC screening tool for co-occurring disorders. Jessup MA; Dibble SL Am J Addict; 2011; 20(3):264-70. PubMed ID: 21477055 [TBL] [Abstract][Full Text] [Related]
17. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample. Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372 [TBL] [Abstract][Full Text] [Related]
18. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Kessler RC; Andrews G; Colpe LJ; Hiripi E; Mroczek DK; Normand SL; Walters EE; Zaslavsky AM Psychol Med; 2002 Aug; 32(6):959-76. PubMed ID: 12214795 [TBL] [Abstract][Full Text] [Related]
19. Smoking and behavioral health of women. Jessup MA; Dibble SL; Cooper BA J Womens Health (Larchmt); 2012 Jul; 21(7):783-91. PubMed ID: 22512870 [TBL] [Abstract][Full Text] [Related]